An NK1 receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Orvepitant (maleate)

Item No. 43077

Technical Information
Formal Name
(2R,4S)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-4-[(8aS)-hexahydro-6-oxopyrrolo[1,2-a]pyrazin-2(1H)-yl]-N-methyl-1-piperidinecarboxamide, (2Z)-2-butenedioate
CAS Number
579475-24-4
Synonyms
  • GW 823296B
Molecular Formula
C31H35F7N4O2 • C4H4O4
Formula Weight
Purity
≥98%
Formulation
A solid
Acetonitrile: Slightly Soluble: 0.1-1 mg/mlChloroform: Slightly Soluble: 0.1-1 mg/ml
SMILES
O=C(O)/C=C\C(O)=O.C[C@H](C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1)N(C)C(N2[C@@H](C3=C(C=C(C=C3)F)C)C[C@@H](N4C[C@@]5([H])N(C(CC5)=O)CC4)CC2)=O
InChi Code
InChI=1S/C31H35F7N4O2.C4H4O4/c1-18-12-23(32)4-6-26(18)27-16-24(40-10-11-41-25(17-40)5-7-28(41)43)8-9-42(27)29(44)39(3)19(2)20-13-21(30(33,34)35)15-22(14-20)31(36,37)38;5-3(6)1-2-4(7)8/h4,6,12-15,19,24-25,27H,5,7-11,16-17H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t19-,24+,25+,27-;/m1./s1
InChi Key
IPACOHTZCSBGBV-WUXDIRCFSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    Orvepitant is a neurokinin-1 (NK1) receptor antagonist (Ki = 0.06 nM for the human receptor).1 It is selective for the NK1 receptor over a panel of 67 transporters, ion channels, and enzymes at 10 µM. Orvepitant inhibits substance P-induced calcium release in CHO cells expressing the recombinant human NK1 receptor (apparent pKB = 10.3). It inhibits GR73632-induced foot tapping in gerbils with half-maximal inhibitory dose (ID50) values of 0.11, 0.09, 0.09, and 3.36 mg/kg when administered 1, 4, 8, or 24 hours prior to GR73632, respectively. Orvepitant also inhibits GR73632-induced hindlimb scratching in gerbils.2 It reduces the number of territorial postures in the human threat test in marmosets, indicating anxiolytic-like activity, when administered at doses of 1, 3, and 10 mg/kg.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Di Fabio, R., Alvaro, G., Braggio, S., et alIdentification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate. Bioorg. Med. Chem. 21(21), 6264-6273 (2013).

    2. Trower, M.K., Fisher, A., Upton, N., et alNeurokinin-1 receptor antagonist orvepitant is an effective inhibitor of itch-associated response in a Mongolian gerbil model of scratching behaviour. Exp. Dermatol. 23(11), 858-860 (2014).